Tatyana K. Ryazanova

Dr. Tatyana K. Ryazanova


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2024 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MKM.N. Kachalkin
M.N. Kachalkin
TRTatyana K. Ryazanova
Tatyana K. Ryazanova
ISI.V. Sokolova
I.V. Sokolova

21 November 2013 in Chemistry of Natural Compounds
Verified
Journal Article
Closed access
PDF file
AKA. V. Kurkina
A. V. Kurkina
TRTatyana K. Ryazanova
Tatyana K. Ryazanova
VKV. A. Kurkin
V. A. Kurkin

1 January 2023 in Journal of Analytical Chemistry
Verified
Journal Article
Closed access
PDF file
ISI. Kh. Shaikhutdinov
I. Kh. Shaikhutdinov
TRTatyana K. Ryazanova
Tatyana K. Ryazanova
LLL. V. Limareva
L. V. Limareva
ASA. V. Sokolov
A. V. Sokolov
We present a critical review of experimental studies of the efficiency of the separation of various groups of chemical compounds under the conditions of high-performance liquid chromatography using metal-organic framework polymers (metal-organic frameworks (MOFs)) or composite materials with MOFs as a stationary phase. MOFs demonstrated many advantages in high-performance liquid chromatography and a possibility of competing successfully with conventional phases, especially in the determination of low-molecular-weight compounds and optical isomers. Among the promising options for using this class of materials are the development of monolithic separation columns and hybrid adsorbents that eliminate the disadvantages of adsorbents based on pure MOFs.

30 August 2022 in Drug development & registration
Verified
Journal Article
Open access
PDF file
VKV. A. Kurkin
V. A. Kurkin
TRTatyana K. Ryazanova
Tatyana K. Ryazanova
Introduction. Nowadays, herbal medicines are becoming more and more popular. In this regard, herbal medicinal preparations based on rhizomes and roots of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim., syn. Acanthopanax senticosus (Rupr. & Maxim.) Harms, are of particular interest. Its have an adaptogenic, immunomodulatory effects mainly due to the presence of phenyl propane compounds: eleutherosides B, D, E, E1. The current pharmacopeial monographs FS.2.5.0053.15 "Eleutherococcus senticosus rhizomes and roots" and FS.3.4.0009.18 "Eleutherococcus senticosus rhizomes and roots liquid extract" in The State Pharmacopoeia of the Russian Federation XIV Edition, in our opinion, does not allow to fully objectively and uniformly assess the quality of raw materials and preparations.Aim. The aim is substantiation of new approaches to quality control of raw materials and preparations of Eleutherococcus senticosus, consisting in changing the conditions of sample preparation and analysis of active biological compounds in comparison with pharmacopoeial methods.Materials and methods. Samples of the medicinal preparation "Eleutherococcus extract liquid" of a domestic manufacturer (5 lots) and experimental preparation "Eleutherococcus syrup". When performing high performance liquid chromatography (HPLC) analysis, a reference sample of syringin was used that met the requirements of pharmacopeial monograph VFS 42-2088-92. Methods of UV-spectroscopy and HPLC were used to determine the quantity of biologically active substances.Results and discussion. As a result of the research, other methodological and methodological approaches have been developed to determine the content of the total of phenylpropanoids in terms of eleutheroside B (syringin) by direct UV-spectrophotometry using a standard sample of syringin or the value of its specific absorbance. New conditions for HPLC analysis of eleutheroside B (syringin) in preparations of Eleutherococcus senticosus have been selected.Conclusion. As a result of the phytochemical study, a spectrophotometric method was developed for the determination of the total of phenylpropanoids in terms of syringin and an HPLC method for the determination of eleutheroside B (syringin) using an external standard after preliminary purification of the total extracts by filtration through a layer of aluminum oxide.

19 August 2021 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
VKV. A. Kurkin
V. A. Kurkin
TRTatyana K. Ryazanova
Tatyana K. Ryazanova
Rhodiola rosea L. rhizomes and roots are pharmacopoeial raw materials, which are used in official medicine for obtaining medicines with adaptogenic activity. One of the most common problems in the production of medicines from Rhodiola rosea L. rhizomes and roots is the use of poor quality medicinal plant materials, which leads to the absence of biologically significant compounds in the preparations. One of the possible reasons is the shortcomings in the existing approaches to the standardization of Rhodiola rosea L. raw materials and preparations.The aim of the study is the improvement of approaches to the standardization of medicinal preparations from Rhodiola rosea L. rhizomes and roots.Materials and methods. Experimental and industrial samples of liquid extract from Rhodiola rosea L. roots, as well as reference samples of rosavin and salidroside, were used as materials of the research. The HPLC analysis was carried out using a Milichrom-6 chromatograph (NPAO Nauchpribor) under the following conditions of reversed-phase chromatography in an isocratic mode: a steel column KAKH-6-80-4 (2 mm x 80 mm; Separon-C18 7 μm), a mobile phase – acetonitrile: 1% solution of acetic acid in water in the ratio of 14:86, the elution rate was 100 μL/min, the eluent volume was 2000 μL. The constituents were detected at the wavelength of 252 nm (rosavin) and 278 nm (salidroside).Results. An assay of rosavin and salidroside in the liquid extract of Rhodiola rosea L. was developed using the HPLC method. It was determined that the content of rosavin in the samples of the liquid extracts obtained from Rhodiola rosea L. rhizomes and roots of the pharmacopoeial quality, varied from 0.21%±0.03% to 0.32%±0.04%, salidroside – from 1.13% ±0.05% to 2.71%±0.12%, respectively. The results of statistical processing indicate that the relative error of the average result for the determination of rosavin and salidroside in the preparations of Rhodiola rosea L. with a confidence level of 95% does not exceed ±6.0%.Conclusion. Thus, methodological approaches to the analysis of medicinal preparations from Rhodiola rosea L. rhizomes and roots have been substantiated. These methodological approaches consist of the quantitative determination of the dominant and diagnostically significant biologically active compounds – rosavin and salidroside.

22 November 2013 in Chemistry of Natural Compounds
Verified
Journal Article
Closed access
PDF file
AKA. V. Kurkina
A. V. Kurkina
TRTatyana K. Ryazanova
Tatyana K. Ryazanova
VKV. A. Kurkin
V. A. Kurkin